Analysis of laboratory parameters in non-traumatic epistaxis

Year 2024, Volume: 15 Issue: 53, 113 - 117, 05.12.2024

Ömer Yüceer , Abdussamed Vural , Turgut Dolanbay , Mustafa Oguz Cumaoglu , Mustafa Doğan Mustafa Cihan Altay , Mustafa Özçelik

Abstract

Objective: The present study investigated the relationship between epistaxis and age, sex, hemogram and coagulation parameters and aimed to set a standard in the approach to epistaxis.
Method: Patients over the age of 18 who presented due to epistaxis between July 1, 2022, and July 1, 2023, were included in this study, and the files of these patients were examined retrospectively. Patients with trauma and chronic hypertension (HT), individuals with diseases that might predispose to bleeding and with a history of bleeding-related drug use such as coumadin derivatives or individuals with malignancy, those who were found to have active infection during the study, patients who were determined to be in the postoperative period, patients whose blood pressure was determined to be above 140/90 mmHg at the time of admission, and those who were found to have blood samples with hemolysis detected in the file records were excluded from the study.
Results: The data of a total of 100 patients, including 62 male and 38 female patients, who presented with complaints of epistaxis, were examined. It was found that more patients at older ages presented to emergency departments with complaints of epistaxis and the number of male patients with epistaxis was higher than female patients. It was concluded that headache is the most common early symptom before spontaneous bleeding in nosebleeds, which are more common in older adults, and platelet values, which are negatively correlated with age and positive correlated with activated partial thromboplastin time (aPTT) and hemoglobin (HGB) are an essential marker for nosebleeds. Furthermore, it was concluded that it is meaningless to check coagulation parameters in patients who are not coumadinized, while checking the hemogram remains important.
Conclusion: It should be kept in mind that headache is the most common early symptom before spontaneous bleeding in nosebleeds, which are more common in older adults, and that platelet values, which negatively correlate with age, are an essential marker for nosebleeds. Additionally, it was concluded that checking coagulation parameters is meaningless in patients who are not coumadinized, while checking the hemogram remains important.

Keywords

Nose bleed, hypertension, platelet, hemoglobin

References

• Epistaxis in Emergency Room: Is Routine Blood Work Always Necessary? Bosphorus Medical Journal. 2017;4(2):89-94
• Ömür M. Epistaxis, Turkish Journal of Family Practice. 1997;1(3):139-42.
• Barnes ML, Spielmann PM, White PS. Epistaxis: a contemporary evidence based approach. Otolaryngol Clin North Am. 2012;45(5):1005-17.
• Reis LR, Correia F, Castelhano L, Escada P. Epidemiology of epistaxis in the emergency department of a southern European tertiary care hospital. Acta Otorrinolaringol Esp (Engl Ed). 2018;69(6):331-8. doi: 10.1016/j.otorri.2017.11.002.
• Bui R, Doan N, Chaaban MR, Epidemiologic and Outcome Analysis of Epistaxis in a Tertiary Care Center Emergency Department. Am J Rhinol Allergy. 2019;34(1):100-7. https://doi.org/10.1177/1945892419876740
• Nunez DA, McClymont LG., Evans RA. Epistaxis: a study of the relationship with weather. Clin Otolaryngol Allied Sci. 1990;15(1): 49-51.
• Stell PM. Epistaxis. Clin Otolaryngol. 1977;2:263-72.
• Viducich RA, Blanda MP, gerson LW. Posterior epistaxis. Ann Emerg Med. 1995;25:592-6. [Abstract]
• Shargorodsky J., Bleier BS., Holbrook EH., et al. Outcomes analysis in epistaxis management: development of a therapeutic algorithm. Otolaryngology Head Neck Surg. 2013; 149(3):390-8.
• Jain NK, Kumar A, Etiological Profile and Treatment Outcome of Epistaxis at a Tertiary Care Hospital in Rural Setup: a prospective review of 90 cases. International J Sci Res. 2015;4(7):813-8.
• Carte FC., Orfoo T., Dias CC., Moura CP., Santos M. Risk factors for the occurrence of epistaxis: Prospective study. Auris Nasus Larynx. 2018;45(3):471-5. doi: 10.1016/j.anl.2017.07.021.
• Hughes JM, Teh BM, Hart CJ, Gibbs HH, Aung AK. 2022. Risk factors and management outcomes in epistaxis: a tertiary centre experience. ANZ J Surg. 2023;93(3):555-60. https://doi.org/10.1111/ans.18179
• Purkey MR, Seeskin Z, Chandra R, Seasonal variation and predictors of epistaxis. Laryngoscope. 2014;124(9):2028-33. doi: 10.1002/lary.24679.
• Yüksel, A, Kurtaran, H, Kankiliç ES, Ark N, Uğur KS, Gündüz M. Epistaxis in geriatric patients. Turk J Med Sci. 2014;44(1):133–6. https://doi.org/10.3906/sag-1301-58
• Ross, A, Engebretsen S, Mahoney R, Bathula S. Risk Factors and Management for Epistaxis in a Hospitalized Adult Sample. Spartan Med Res J. 2022;7(2);37760. https://doi.org/10.51894/001c.37760
• Akdoğan M, Tanrıkulu S, Türkoğlu Babakurban S, Gokdemır M. Complete Blood Count Parameters in Recurrent Pediatric Idiopathic Epistaxis. Kulak Burun Boğaz ve Baş Boyun Cerrahisi. 2019;27(3), 97-103. 10.24179/kbbbbc.2019-71049
• Fritschi J, Raddatz-Muller P, Schmid P, Wuillemin WA. Patient self-management of long-term oral anticoagulation in Switzerland. Swiss Med.Wkly. 2007;137:252-8.
• Soyka MB, Holzmann D. Should we test the Prothrombin time in anticoagulated Epistaxis Patients? Allergy Rhinol (Providence). 2013. 4(1):e52-e53. doi: 10.2500/ar.2013.4.0049
• Celkan T, Yılmaz İ, Demiral A, Çam H, Karaman S, Doğru Ö, Apak H, Özkan A, Taştan Y, Yıldız İ. Bleeding disorders in pediatric emergency department. Türk Pediatri Arşivi. 2006;41;146-50. Kaan H, Karayağmurlu A, Successful management of methylphenidata related thrombocytopenia during ADHD treatment: a case report. Anatolian Journal of Psychiatry. 2020;2(5):557-60.
• Razdan U, Raizada RM, Chaturvedi VN. Efficacy of conservative treatment modalities used in epistaxis. Indian J Otolaryngol Head Neck Surg. 2004;56:20-2.
• Ekmekyapar M, Sahin L, Gur A. Comparison of the therapeutic efficacy of topical tranexamic acid, epinephrine, and lidocaine in stopping bleeding in non-traumatic epistaxis: a prospective, randomized, double-blind study. Eur Rev Med Pharmacol Sci. 2022;26(9):3334-41.